Beddow Capital Management Inc. Buys 22,635 Shares of CVS Health Co. (NYSE:CVS)

Beddow Capital Management Inc. lifted its stake in shares of CVS Health Co. (NYSE:CVS) by 71.9% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 54,135 shares of the pharmacy operator’s stock after buying an additional 22,635 shares during the period. CVS Health comprises approximately 1.4% of Beddow Capital Management Inc.’s investment portfolio, making the stock its 29th biggest position. Beddow Capital Management Inc.’s holdings in CVS Health were worth $3,197,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Ables Iannone Moore & Associates Inc. bought a new position in CVS Health in the fourth quarter valued at about $32,000. First Community Trust NA grew its holdings in CVS Health by 116.2% during the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 302 shares during the last quarter. Creekmur Asset Management LLC bought a new position in shares of CVS Health during the fourth quarter valued at $34,000. Steph & Co. lifted its holdings in shares of CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares during the period. Finally, ORG Partners LLC grew its stake in shares of CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 592 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Stock Down 1.5 %

Shares of NYSE CVS opened at $57.51 on Friday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The stock has a market capitalization of $72.20 billion, a P/E ratio of 10.11, a P/E/G ratio of 0.79 and a beta of 0.53. The company has a 50-day moving average price of $58.31 and a 200-day moving average price of $62.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business posted $2.21 earnings per share. On average, equities research analysts forecast that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.63%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s payout ratio is currently 46.75%.

Wall Street Analyst Weigh In

CVS has been the topic of several recent research reports. JPMorgan Chase & Co. cut their target price on CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a report on Thursday, May 30th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a research note on Monday, September 16th. Robert W. Baird initiated coverage on shares of CVS Health in a research report on Thursday, May 30th. They set a “neutral” rating and a $61.00 target price for the company. Evercore ISI dropped their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Finally, Wells Fargo & Company increased their price objective on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. Eleven investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus price target of $72.10.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.